VTGN
VTGN
NASDAQ · Biotechnology

Vistagen Therapeutics Inc

$0.30
+0.02 (+8.79%)
Analyst Consensus
Sell
10
Analysts
Moderate
Coverage
Buy 0 0%
Hold 7 70%
Sell 3 30%
Price Target
Analyst Price Target +16,556.6% upside
Low Target $36.23
Average Target $49.47
High Target $53.77
Current Price $0.30
Current
$0.30
Target
$49.47
$36.23 $49.47 avg $53.77
Scenario Analysis
Bear Case
$36.23
12,098.7%
Low target
Base Case
$49.47
+16,556.6%
Avg target
Bull Case
$53.77
+18,004.4%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$5.14
-94.2% from high
52-Week Low
$0.20
+50.0% from low
Target vs 52W High
$49.47
+862.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%